Terrain Variation for Plantar Fasciitis
Trial Summary
What is the purpose of this trial?
Modern footwear has been implicated as a contributor to foot pathology and changes in the biomechanics of gait. In addition to footwear, the investigators propose that the lack of terrain variation may directly contribute to the development of common foot pathologies, resulting from decreased intrinsic foot muscle function. This study will examine the current understanding of terrain variation on foot musculature strength and its possible correlation with structural and functional changes within the foot.
Will I have to stop taking my current medications?
Yes, if you are currently taking any anti-inflammatory medication or medication to control nerve issues, you will need to stop, as these are not allowed for participation in the trial.
How does the Terrain Variation treatment for plantar fasciitis differ from other treatments?
The Terrain Variation treatment for plantar fasciitis is unique because it focuses on altering the walking or running surface to address biomechanical factors, unlike traditional treatments that may focus on medication or physical therapy alone. This approach aims to modify the forces on the foot during movement, potentially reducing the overload on the plantar fascia.12345
Research Team
Antony Merendino, DPM
Principal Investigator
University of Florida
Eligibility Criteria
This trial is for adults over 18 in Gainesville who either have healthy feet or suffer from plantar fasciitis, experiencing heel pain that hasn't improved with standard treatments like stretching, medication, and supportive insoles for at least 6 months.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants will utilize a minimalist shoe and follow a training protocol on either natural terrain or hardscapes
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Terrain Variation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor